Luye Pharma Group Profit Margin

Luye Pharma Group (LYPHF) currently reports a profit margin of 8.87% as of June 2026. That compares with 9.95% in the prior-year period — down 10.8% year over year. That is below the sector sector average of 13.16%. Use the charts on this page to explore Luye Pharma Group's profit margin history and peer comparisons.

Luye Pharma Group's profit margin decreased from 9.95% to 8.87% — a 10.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Luye Pharma Group's profit margin of 8.87% is lower than the its sector sector average of 13.16%. That is roughly 32.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Luye Pharma Group's current 8.87% should be judged against industry norms (sector average: 13.16%) and against LYPHF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 8.87%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.16%. From there, open related valuation or income-statement pages for Luye Pharma Group, and consider following LYPHF for alerts when major investors trade the stock.